“Re.St.Les. to treat Epilepsy” Chosen for I-Corps@Ohio

“Re.St.Les. to treat Epilepsy” Chosen for I-Corps@Ohio

The project team behind “Re.St.Les.” a neurosurgical platform invented at Cleveland Clinic, has been selected for the 2019 cohort of I-Corps@Ohio. This technology is a minimally-invasive alternative to open brain surgery by Drs. Jorge Gonzalez-Martinez, Andre Machado and Imad Najm to combine Recording, Stimulation and Lesioning of epileptogenic tissue into an integrated product. Thanks to support from the Neurological Institute, the device has been developed, prototyped and tested by a project team comprised of Ahmet Erdemir, PhD and Erica Neumann, both from the Department of Biomedical Engineering and Jon Sakai from Cleveland Clinic Innovations.

I-Corps@Ohio is a state-funded program intended to build a pipeline of startups from technologies developed at Ohio’s colleges, universities and research institutions. During an intensive 8-week program, the project team will receive commercialization training and challenge their business model by interviewing dozens of stakeholders. At the end of the program teams will have a full business plan and a well-honed pitch deck for presentation to potential investors.

This opportunity will allow for the further development of the Re.St.Les. technology in the hopes of bringing it from bench to bedside.

The next cohort for I-Corps@Ohio will begin in the summer of 2019.
 

Get In Touch With Us